Edmond DE Rothschild Holding S.A. Reduces Holdings in Perrigo Company plc (NYSE:PRGO)

Edmond DE Rothschild Holding S.A. lessened its holdings in Perrigo Company plc (NYSE:PRGO) by 0.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,215,000 shares of the company’s stock after selling 10,000 shares during the period. Edmond DE Rothschild Holding S.A. owned 0.89% of Perrigo worth $31,238,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Citigroup Inc. grew its holdings in Perrigo by 94.1% during the 3rd quarter. Citigroup Inc. now owns 151,520 shares of the company’s stock valued at $3,974,000 after buying an additional 73,457 shares during the last quarter. Bank of Montreal Can boosted its stake in shares of Perrigo by 347.0% during the third quarter. Bank of Montreal Can now owns 145,474 shares of the company’s stock valued at $3,731,000 after acquiring an additional 112,929 shares during the last quarter. FMR LLC raised its stake in Perrigo by 66,795.3% in the 3rd quarter. FMR LLC now owns 1,840,289 shares of the company’s stock valued at $48,271,000 after purchasing an additional 1,837,538 shares during the last quarter. BNP Paribas Financial Markets lifted its holdings in Perrigo by 43.8% in the 3rd quarter. BNP Paribas Financial Markets now owns 114,937 shares of the company’s stock valued at $3,015,000 after purchasing an additional 35,031 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in shares of Perrigo by 1.2% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 419,137 shares of the company’s stock worth $10,994,000 after purchasing an additional 5,141 shares during the last quarter. 95.91% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Perrigo news, EVP Ronald Craig Janish sold 7,800 shares of the firm’s stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $27.44, for a total transaction of $214,032.00. Following the completion of the sale, the executive vice president now owns 33,666 shares in the company, valued at $923,795.04. This trade represents a 18.81 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.70% of the stock is currently owned by insiders.

Perrigo Stock Up 1.1 %

Shares of NYSE PRGO opened at $28.06 on Monday. The stock has a market capitalization of $3.83 billion, a PE ratio of -23.98 and a beta of 0.48. The company has a quick ratio of 1.77, a current ratio of 2.56 and a debt-to-equity ratio of 0.94. The firm has a fifty day moving average of $26.11 and a 200-day moving average of $26.15. Perrigo Company plc has a 52-week low of $23.14 and a 52-week high of $33.46.

Perrigo (NYSE:PRGO) last posted its earnings results on Thursday, February 27th. The company reported $0.93 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.92 by $0.01. Perrigo had a negative net margin of 3.64% and a positive return on equity of 7.38%. The firm had revenue of $1.14 billion during the quarter, compared to the consensus estimate of $1.20 billion. On average, analysts anticipate that Perrigo Company plc will post 2.56 EPS for the current year.

Perrigo Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 25th. Stockholders of record on Friday, March 7th were paid a $0.29 dividend. The ex-dividend date of this dividend was Friday, March 7th. This is an increase from Perrigo’s previous quarterly dividend of $0.28. This represents a $1.16 annualized dividend and a dividend yield of 4.13%. Perrigo’s dividend payout ratio is -92.80%.

Wall Street Analysts Forecast Growth

PRGO has been the topic of several recent analyst reports. Piper Sandler downgraded shares of Perrigo from an “overweight” rating to a “neutral” rating and reduced their price objective for the company from $34.00 to $27.00 in a research note on Monday, January 6th. StockNews.com cut Perrigo from a “buy” rating to a “hold” rating in a report on Wednesday, February 19th. Finally, Argus lowered Perrigo from a “buy” rating to a “hold” rating in a research note on Tuesday, January 14th. Four investment analysts have rated the stock with a hold rating and one has issued a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $33.00.

Perrigo Profile

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.